Skip to main content
. 2023 Oct 23;12(20):6683. doi: 10.3390/jcm12206683

Figure 2.

Figure 2

Comparisons of the effects of high and low expression levels of NF-κB p65 (RelA) and TNFα on the survival time of GBM patients using the GEPIA database. (a) Elevated expression levels of NF-κB p65 (RelA) were associated with poor OS; low NF-κB p65 (RelA) has a higher median survival in GBM patients. (b) Low expression of TNFα alpha has a higher median survival in GBM patients but is not statistically significant. The 95% CI is shown by the dotted lines in both (a,b). (c) Effect of NF-κB p65 (RelA) expression levels in UALCAN on the survival of GBM patients. (d) Effect of TNFα expression levels in UALCAN on the survival of GBM patients.